Firefly Neuroscience (AIFF) Gross Margin (2010 - 2026)

Firefly Neuroscience has reported Gross Margin for 16 years, with the latest figure at 49.22% in Q2 2026.

• On a quarterly basis, Gross Margin fell 4242.0% year-over-year to 49.22% in Q2 2026; TTM through Jun 2026 was 44.58%, a 4945.0% decrease from a year earlier, with the FY2025 full-year figure at 56.48%, down 4352.0% from the prior year.
• Gross Margin was 49.22% for Q2 2026 at Firefly Neuroscience, up from 45.57% in the prior quarter.
• The five-year high for Gross Margin was 5827.15% in Q1 2024, with the low at 23.25% in Q1 2022.
• Average Gross Margin over 5 years is 739.05%, with a median of 45.57% recorded in 2026.
• The sharpest annual moves came in 2024 and 2025: Gross Margin jumped 579674 bps in 2024, then slumped 572715 bps in 2025.
• Over 5 years, Gross Margin stood at 26.59% in 2022, then jumped by 11830 bps to 3171.97% in 2023, then plunged by 97 bps to 100.0% in 2024, then plunged by 56 bps to 44.17% in 2025, then increased by 11 bps to 49.22% in 2026.
• The last three Gross Margin figures came in at 49.22% (Q2 2026), 45.57% (Q1 2026), and 44.17% (Q4 2025), per Business Quant data.